Reuters: Health
AbbVie Inc on Thursday said it will discontinue the late-stage trial testing its experimental treatment for a type of lung cancer after it failed to show a survival benefit compared to placebo.
AbbVie terminates late-stage lung cancer trial
AbbVie terminates late-stage lung cancer trial
Reuters: Health
AbbVie Inc on Thursday said it will discontinue the late-stage trial testing its experimental treatment for a type of lung cancer after it failed to show a survival benefit compared to placebo.
Reuters: Health
AbbVie Inc on Thursday said it will discontinue the late-stage trial testing its experimental treatment for a type of lung cancer after it failed to show a survival benefit compared to placebo.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment